Navigation Links
Corgenix Reports Financial Results for First Quarter of Fiscal 2009
Date:11/13/2008

interested in hearing management's discussion of fiscal year results to join a shareholders conference call on Thursday, November 13, 2008, at 4:00 PM EST (2:00 PM MST). Interested parties can join the call by dialing (800) 895-0198. International participants may access the call by dialing +1 785 424 1053. The conference code is "CORGENIX." A replay will be available for 30 days following the call by dialing (800) 723-0544 for U.S. participants and +1 402 220 2656 for international participants.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world's only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at http://www.corgenix.com.

Statements in this press release that are not strictly historical facts are "forward looking" statements (identified by the words "believe", "estimate", "project", "expect" or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, bas
'/>"/>

SOURCE Corgenix Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Corgenix Announces Expansion of Hemorrhagic Fever Virus Product Development Program
2. Corgenix Reports Third Quarter Fiscal 2008 Financial Results
3. Corgenix to Exhibit AspirinWorks(R) Test at 2008 ACOFP Meeting in Denver
4. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
5. Spheris Reports Third Quarter 2008 Results
6. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
7. Symmetry Medical Reports Third Quarter 2008 Financial Results
8. EntreMed Reports Clinical Program Progress and Company Update
9. NBTY Reports Fourth Quarter and Fiscal Year Results
10. IPC The Hospitalist Company Reports Record Third Quarter 2008 Results
11. Consumer Reports Survey: Nearly Half of Adults Wont Get Flu Vaccine, Citing Poor Excuses Like I Dont Get Sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... York, NY (PRWEB) December 20, 2014 The ... has caused quite a stir, not only in Hollywood, but ... on December 18th , the ripples of that attack are ... executives’ very jobs at risk. But they are not ... correspondences exposed could be in for some embarrassing times ahead, ...
(Date:12/20/2014)... Parker & Sons, Inc. a focused and dedicated ... contractor services announces reaching a milestone by providing 40 ... Arizona. Parker and Sons is comprised of a reliable ... customer service the number one priority. The company was ... one service vehicle and has since grown to become ...
(Date:12/19/2014)... December 19, 2014 Sub Zero Ice Cream ... a blood drive Sunday the 28th from 2pm-6pm at the ... Sawyer Road in Sarasota, FL. , Inquiries regarding time slots ... for participating in the donating process, Sub Zero Ice Cream ... frozen, custom ice cream. , About Sub Zero Ice Cream ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Eufaula, Oklahoma, ... to Lake Eufaula, the state’s largest lake with more ... town is home to a little more than 3,000 ... P.M. on Saturday, the 6th of December. , Featuring ... way through downtown Eufaula on Main Street. Narconon ...
(Date:12/19/2014)... News) -- New research warns parents that buying an older car ... Nearly half of teen drivers killed in the United States between ... years old and often lacked important safety features that are available ... drivers killed in crashes were in cars at least six years ... 31 percent were in cars 11 to 15 years old, and ...
Breaking Medicine News(10 mins):Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Older Cars a Bad Choice for Younger Drivers 2
... after a gap of 22 years, the World Health Organisation ... three-year-old Somali child at Dadaab refugee camp in northeast Kenya. ... had reported outbreak of polio cases in 2005, according to ... Fadela Chaib said the successful control of polio worldwide would ...
... of chemotherapy patients has increased the demand for blood components. ... ,According to the Irish Blood Transfusion Service and the Irish ... a 50% increase in the demand for blood components due ... can be met by over 22,000 donations of platelets every ...
... called IRF6 is involved in the common birth defect cleft ... J. and// Lucille A. Carver College of Medicine and their ... findings, published online Oct. 15 in Nature Genetics, reveal an ... skin cells, a discovery that may have implications for wound ...
... The two recent government-sponsored reports released on Tuesday revealed ... the risks due to contamination. These reports// are based ... major health outcomes among adults, the benefits of eating ... been lost on the public," said Dr. Dariush Mozaffarian, ...
... been approved for its treatment by the FDA, following ... chemotherapy with// Taxotere survived an average of 11.4 months ... standard drugs. ,The drug will be used ... in locally advanced squamous cell head and neck cancer. ...
... is no more restricted to just risk groups alone in ... each day according to statistics with almost one percent of ... is alarming to note that like Africa, which has the ... is now common through even heterosexual contact China too has ...
Cached Medicine News:Health News:Chemotherapy increases the demand for blood components 2Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 2Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 3Health News:Eating Fish has more Benefits than Risks 2
(Date:12/17/2014)... Los beneficios y ganancias están ... de gasto en investigación y desarrollo   ... de septiembre de 2014) ZEISS aumentó sus ingresos en ... (año anterior: 4.190 millones de euros) a pesar de ... crecieron un 14 por ciento, a 360 millones de ...
(Date:12/17/2014)... 2014  Northstar Global Business Services, Inc. (OTCPink:MDIN) ... has made their final decision and has determined ... stock effective December 15, 2014, and has resumed ... and book entry transfer services. All deposit restrictions have ... again fully "DTC Eligible", and has resumed electronic ...
(Date:12/17/2014)... , The new Dompé website aims ... the biopharmaceutical Group,s national and international clinical research activities ... launched institutional website that is receiving accolades from all over ... chapter in the fascinating story of Drug Discovery   , ... on the world of clinical research, ranging from information for ...
Breaking Medicine Technology:ZEISS confirma su posición en un entorno difícil 2Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3
... British Columbia, Nov. 2, 2010 VIDA Diagnostics, ... announces the introduction of its Apollo™ Pulmonary Evaluation ... analysis of major lung diseases, including COPD, asthma, ... in Vancouver, BC.   Apollo strengthens ...
... HAYWARD, Calif., Nov. 2, 2010 Anthera Pharmaceuticals, Inc. (Nasdaq: ... highlights for the third quarter ended September 30, 2010. ... for the third quarter ended September 30, 2010, were $8.4 ... in 2009. For the nine months ended September 30, 2010, ...
Cached Medicine Technology:VIDA Diagnostics Introduces Apollo™ 2Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update 5
... Triad Plus PVP-I Prep Gel ... PVP-I Prep Gel is film forming, ... action that has been known to ... gram-positive bacteria (including antibiotic resistant), fungi, ...
... HIBICLENS bonds with ... a protective, germ-killing field. ... fast acting antimicrobial effect, ... irritation potential promotes compliance ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
Medicine Products: